Research & Development

Breakthrough DNA Analysis Unveils Shared Ancestry in All Modern Humans
Research & Development Breakthrough DNA Analysis Unveils Shared Ancestry in All Modern Humans

Human evolution has always captured our imagination, leading to discoveries that continuously reshape our understanding of our origins. Researchers at the University of Cambridge have made a significant breakthrough, revealing that all modern humans share DNA from two ancient populations. These

Immunovant Shifts Focus to Next-Gen Drug IMVT-1402 Amid Trial Success
Research & Development Immunovant Shifts Focus to Next-Gen Drug IMVT-1402 Amid Trial Success

Immunovant, a biotechnology company known for its innovative treatments for autoimmune diseases, has recently announced a significant shift in its development strategy. Despite late-stage successes with its experimental drug batoclimab, the company has decided to momentarily hold back on seeking

Prime Medicine Advances Gene Editing for Alpha-1 Antitrypsin Deficiency
Research & Development Prime Medicine Advances Gene Editing for Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that significantly impacts both liver and lung function, resulting in a rare but severe health burden. In an ambitious and promising development, Prime Medicine is leveraging its innovative gene editing technology to address this

Med-Life Discoveries Completes Phase I Trial for PPI-1011 Therapy
Research & Development Med-Life Discoveries Completes Phase I Trial for PPI-1011 Therapy

Ivan Kairatov is a Biopharma expert with deep knowledge of tech and innovation in the industry and experience in research and development. Today, we are discussing Med-Life Discoveries (MLD), their mission, and the promising results of their Phase I study on PPI-1011, a synthetic plasmalogen

NIH Funds Research on Cranial Therapy for Traumatic Brain Injury
Research & Development NIH Funds Research on Cranial Therapy for Traumatic Brain Injury

Research on cranial osteopathic manipulation for TBI treatment has received $2.17 million from the NIH. This funding supports Virginia Tech’s Pamela VandeVord and Edward Via College of Osteopathic Medicine’s Gunnar Brolinson. Their collective efforts aim to explore innovative non-invasive str

RAS Inhibition and Immunotherapy: A Breakthrough for Pancreatic Cancer
Research & Development RAS Inhibition and Immunotherapy: A Breakthrough for Pancreatic Cancer

Pancreatic cancer, recognized for its aggressive nature and limited treatment options, remains one of the most challenging malignancies to manage. Researchers at the Perelman School of Medicine, University of Pennsylvania, and Penn Medicine's Abramson Cancer Center have recently unveiled

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later